HC Wainwright Reiterates Buy Rating on Evotec, Sets $4 Target

HC Wainwright reiterated its Buy rating on Evotec and set a $4.00 price target. The target implies 63.7% upside from the Oct. 13 close of $2.44. Evotec management reaffirmed FY26 revenue guidance, according to the analyst note.